News & Events about Durect Corp.
DURECT Corporation to Announce Third Quarter 2022 Financial Results and Provide Business Update on November 2 DURECT Corporation to Announce Third Quarter 2022 Financial Results and Provide Business Update on November 2 PR Newswire CUPERTINO, Calif., Oct. 26, 2022 CUPERTINO, Calif., Oct. 26, 2022...
DURECT Reaches Enrollment Milestone in Phase 2b AHFIRM Trial DURECT Reaches Enrollment Milestone in Phase 2b AHFIRM Trial PR Newswire CUPERTINO, Calif., Oct. 6, 2022 AHFIRM enrollment surpasses 200 of the planned 300 AH patients Enrollment completion now anticipated in Q2 2023CUPERTINO, Calif...
Innocoll and DURECT Announce U.S. launch of POSIMIR Innocoll and DURECT Announce U.S. launch of POSIMIR PR Newswire ATHLONE, Ireland and CUPERTINO, Calif., Sept. 26, 2022 POSIMIR is now commercially available in the U.S. for the treatment of post-surgical pain in adults following arthroscopic...
DURECT Corporation Appoints Timothy M. Papp as Chief Financial Officer DURECT Corporation Appoints Timothy M. Papp as Chief Financial Officer PR Newswire CUPERTINO, Calif., July 5, 2022 CUPERTINO, Calif., July 5, 2022 /PRNewswire/ --DURECT Corporation(Nasdaq: DRRX), a biopharmaceutical company...
DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference PR Newswire CUPERTINO, Calif., May 18, 2022 CUPERTINO, Calif., May 18, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today...